Susquehanna International Group’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Sell |
135,162
-1,241,891
| -90% | -$11.5M | ﹤0.01% | 2906 |
|
|
2025
Q1 | $9.27M | Buy |
1,377,053
+1,294,458
| +1,567% | +$8.71M | ﹤0.01% | 691 |
|
|
2024
Q4 | $877K | Buy |
82,595
+30,964
| +60% | +$329K | ﹤0.01% | 3194 |
|
|
2024
Q3 | $755K | Buy |
51,631
+21,920
| +74% | +$320K | ﹤0.01% | 3066 |
|
|
2024
Q2 | $360K | Sell |
29,711
-289,803
| -91% | -$3.51M | ﹤0.01% | 3982 |
|
|
2024
Q1 | $7.89M | Buy |
319,514
+284,687
| +817% | +$7.03M | ﹤0.01% | 781 |
|
|
2023
Q4 | $373K | Buy |
34,827
+9,698
| +39% | +$104K | ﹤0.01% | 4261 |
|
|
2023
Q3 | $210K | Buy |
25,129
+7,665
| +44% | +$64K | ﹤0.01% | 4496 |
|
|
2023
Q2 | $138K | Buy |
17,464
+4,913
| +39% | +$38.9K | ﹤0.01% | 4850 |
|
|
2023
Q1 | $62.6K | Sell |
12,551
-9,513
| -43% | -$47.5K | ﹤0.01% | 5390 |
|
|
2022
Q4 | $48.5K | Buy |
+22,064
| New | +$48.5K | ﹤0.01% | 5172 |
|
|
2022
Q3 | – | Sell |
-12,052
| Closed | -$39K | – | 6500 |
|
|
2022
Q2 | $39K | Sell |
12,052
-21,715
| -64% | -$70.3K | ﹤0.01% | 5298 |
|
|
2022
Q1 | $192K | Sell |
33,767
-31,682
| -48% | -$180K | ﹤0.01% | 4849 |
|
|
2021
Q4 | $848K | Buy |
65,449
+6,568
| +11% | +$85.1K | ﹤0.01% | 3073 |
|
|
2021
Q3 | $1.43M | Buy |
+58,881
| New | +$1.43M | ﹤0.01% | 2323 |
|